SCHEMBL8286507

SCHEMBL8286507

Cc1ccc(-c2cc3c(cn2)c(=O)cc(Nc2ccccc2)n3-c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.37
FFAR4 Q5NUL3 1/20 0.37
MAPT P10636 5/20 0.36
TP53 P04637 3/20 0.36
GAA P10253 2/20 0.36
HPGD P15428 2/20 0.36
CSF1R P07333 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 3/20 0.36
CYP2C9 P11712 1/20 0.36
ADORA3 P0DMS8 1/20 0.35
ALDH1A1 P00352 5/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
LMNA P02545 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
NPC1 O15118 1/20 0.35
STAT1 P42224 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285278 0.92 MAPK1 (0.38) GSK3BGAAHPGDMAPK1HTT
SCHEMBL8286511 0.89 MAT2A (0.38) GSK3BCSF1RMAPK1ADORA3ALDH1A1
SCHEMBL8285319 0.86 PIK3CA (0.43) GSK3BMAPTGAAHPGDMAPK1
SCHEMBL5872050 0.84 GAA (0.44) GSK3BMAPTGAAHPGDMAPK1
SCHEMBL8286496 0.83 FYN (0.37) GSK3BALDH1A1POLBNPC1CDK4
SCHEMBL8285307 0.83 ATR (0.42) GSK3BMAPTTP53CSF1RALDH1A1
SCHEMBL8287576 0.81 GSK3B (0.39) GSK3BMAPTGAAHPGDMAPK1
SCHEMBL8362929 0.80 PIK3CA (0.44) GSK3BMAPTGAAHPGDMAPK1
SCHEMBL8286490 0.80 PIK3CA (0.47) GSK3BMAPTTP53NPSR1NPC1
SCHEMBL8286508 0.80 LOXL3 (0.42) GAAHPGDCYP2C9ADORA3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed